Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck-Geisinger Collaboration Aims For “Pipeline” Of Treatment Adherence Tools

Executive Summary

The first tool that will be developed is an interactive web application designed to help primary care clinicians assess and engage patients at risk for cardiometabolic syndrome.

Advertisement

Related Content

Driving Rx Adherence In Value-Based Insurance Design Needs More Than Lower Copays – Harvard Researcher
Making The Business Of Drug Adherence An Easier Pill To Swallow
Pharma/Payer Deals: 2011 Saw Important Step In Shift To Value-based R&D
Merck's Juvisync Becomes First Fixed-Dose Diabetes/Cholesterol Treatment
Merck Adds To Diabetes Franchise With SmartCells Acquisition

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS054542

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel